-- 根据制药公司RPG Life Sciences（NSE:RPGLIFE，BOM:532983）周三向印度证券交易所提交的文件，该公司第四财季利润暴跌至2.99亿印度卢比，而去年同期为11.7亿卢比。 该公司股价在周四的交易中上涨超过11%。 截至3月31日的季度，每股收益从去年同期的70.96卢比降至18.08卢比。 第四财季营业收入从去年同期的14.3亿卢比增至17.7亿卢比。 董事会建议派发截至3月31日财年的末期股息，每股0.24卢比。
Related Articles
Mining & Metals
AltaGas' Q1 Normalized Net Income Rises YoY, On Track to Hit Top End of 2026 Guidance
AltaGas (ALA.TO) Thursday reported higher normalized net income in the first quarter and said it is on track to deliver 2026 results at the top end of its guidance.Normalized net income was C$415 million, or $1.33 per share, up from $342 million, or $1.14 per share. The result beat the non-GAAP earnings per share consensus estimate of $1.24 for the first quarter, as compiled by FactSet.Revenue held steady year over year at $3.97 billion. The result missed the sales consensus estimate of $4.13 billion, as compiled by FactSet.Normalized EBITDA was $818 million, up from $689 million.The growth in normalized EBITDA was attributed to higher global export volumes and margins, stronger processing and liquids handling margins, new utilities rates in D.C. and Virginia, strong asset optimization, and partial settlement of a pension liability.AltaGas expects to deliver 2026 results toward the top end of guidance for both normalized EBITDA and normalized EPS, with upside potential from continued LPG market strength.The company reiterated 2026 normalized EBITDA guidance of $1.925 billion to $2.025 billion; and normalized EPS guidance of $2.20 to $2.45.The company increased its 2026 capital program to $1.7 billion.
$ALA.TO
Research
UOB Kay Hian Downgrades AP Thailand to Hold from Buy; Price Target is THB8.50
$BKK:AP
Research
Maybank Research Upgrades Bumrungrad Hospital to Buy from Hold; Price Target is THB215
$BKK:BH